Loading...

CNTB CONNECT BIOPHARMA HOLDINGS LTD US FDA Inspections 8-K Filing

CNNC

CNTB

CONNECT BIOPHARMA HOLDINGS LTD

(CNTB)

2025 8-K

Financial Results Released

Share Placement Funding

Board Resignation

Financial Results Announced

Insider Share Purchases

Financial Results Released

Equity Offerings

New Drug Application

Financial Statements

Market Expansion

Product Expansion

FDA Meeting Update

Financial Results

Nasdaq Compliance Notice

Management Changes

Management Changes

Financial Results Update

Management Changes

Management Changes

Financial Results Announcement

Board Appointment

External Links:

On April 1, 2025, Connect Biopharma Holdings Limited announced positive feedback from the FDA regarding their Type C meeting, and plans to start Phase 2 trials for rademikibart in asthma and COPD patients, enrolling about 320 patients total.

AI Assistant

CONNECT BIOPHARMA HOLDINGS LTD

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.